Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Status and Forecast 2021-2027

Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Aspirin
1.2.3 Ibuprofen
1.2.4 Naproxen
1.2.5 Celecoxib
1.2.6 Others
1.3 Market by Application
1.3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Drug Store
1.3.3 Hospital Pharmacies
1.3.4 Online
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2016-2027)
2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Regions
2.2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Share by Regions (2016-2021)
2.2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2022-2027)
2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Dynamic
2.3.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends
2.3.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
2.3.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
2.3.4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue
3.1.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue (2016-2021)
3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2016-2021)
3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue
3.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio
3.4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2020
3.5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served
3.6 Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
3.7 Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Type
4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2016-2021)
4.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2022-2027)
5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Application
5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Application (2016-2021)
5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027)
6.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
6.2.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021)
6.2.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027)
6.2.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027)
6.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
6.3.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021)
6.3.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027)
6.3.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027)
6.4 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
6.4.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021)
6.4.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027)
7.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
7.2.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021)
7.2.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027)
7.2.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027)
7.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
7.3.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021)
7.3.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027)
7.3.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027)
7.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
7.4.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021)
7.4.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027)
8.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
8.2.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027)
8.3 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
8.3.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027)
8.4 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region
8.4.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027)
9.2 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
9.2.1 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021)
9.2.2 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027)
9.2.3 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027)
9.3 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
9.3.1 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021)
9.3.2 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027)
9.3.3 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027)
9.4 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
9.4.1 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021)
9.4.2 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027)
10.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
10.2.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027)
10.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
10.3.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027)
10.4 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
10.4.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche (Genentech)
11.1.1 Roche (Genentech) Company Details
11.1.2 Roche (Genentech) Business Overview
11.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.1.4 Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.1.5 Roche (Genentech) Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.2.4 Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 B-MS
11.3.1 B-MS Company Details
11.3.2 B-MS Business Overview
11.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.3.4 B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.3.5 B-MS Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.4.4 Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.5.4 Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.6.4 Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.7.4 Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.7.5 Eli Lilly and Company Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.8.4 Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.8.5 Johnson & Johnson Recent Development
11.9 GSK
11.9.1 GSK Company Details
11.9.2 GSK Business Overview
11.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.9.4 GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.9.5 GSK Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.10.4 Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.10.5 Sanofi Recent Development
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Company Details
11.11.2 Boehringer Ingelheim Business Overview
11.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.11.4 Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.11.5 Boehringer Ingelheim Recent Development
11.12 Zhejiang Jiuzhou Pharmaceutical
11.12.1 Zhejiang Jiuzhou Pharmaceutical Company Details
11.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
11.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Aspirin
Table 3. Key Players of Ibuprofen
Table 4. Key Players of Naproxen
Table 5. Key Players of Celecoxib
Table 6. Key Players of Others
Table 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2016-2021)
Table 11. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2022-2027)
Table 13. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends
Table 14. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
Table 15. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
Table 16. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
Table 17. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players (2016-2021)
Table 19. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2020)
Table 20. Ranking of Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
Table 24. Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2016-2021)
Table 28. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2016-2021)
Table 32. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) & (US$ Million)
Table 64. Roche (Genentech) Company Details
Table 65. Roche (Genentech) Business Overview
Table 66. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 67. Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 68. Roche (Genentech) Recent Development
Table 69. Amgen Company Details
Table 70. Amgen Business Overview
Table 71. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 72. Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 73. Amgen Recent Development
Table 74. B-MS Company Details
Table 75. B-MS Business Overview
Table 76. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 77. B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 78. B-MS Recent Development
Table 79. Merck Company Details
Table 80. Merck Business Overview
Table 81. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 82. Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 83. Merck Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 87. Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 88. Pfizer Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 92. Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Eli Lilly and Company Company Details
Table 95. Eli Lilly and Company Business Overview
Table 96. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 97. Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 98. Eli Lilly and Company Recent Development
Table 99. Johnson & Johnson Company Details
Table 100. Johnson & Johnson Business Overview
Table 101. Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 102. Johnson & Johnson Recent Development
Table 103. GSK Company Details
Table 104. GSK Business Overview
Table 105. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 106. GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 107. GSK Recent Development
Table 108. Sanofi Company Details
Table 109. Sanofi Business Overview
Table 110. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 111. Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 112. Sanofi Recent Development
Table 113. Boehringer Ingelheim Company Details
Table 114. Boehringer Ingelheim Business Overview
Table 115. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 116. Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 117. Boehringer Ingelheim Recent Development
Table 118. Zhejiang Jiuzhou Pharmaceutical Company Details
Table 119. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 120. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 121. Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 122. Zhejiang Jiuzhou Pharmaceutical Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type: 2020 VS 2027
Figure 2. Aspirin Features
Figure 3. Ibuprofen Features
Figure 4. Naproxen Features
Figure 5. Celecoxib Features
Figure 6. Others Features
Figure 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2020 VS 2027
Figure 8. Drug Store Case Studies
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Case Studies
Figure 11. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered
Figure 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions: 2020 VS 2027
Figure 15. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2022-2027)
Figure 16. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players in 2020
Figure 17. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2020
Figure 19. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2016-2021)
Figure 20. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2022-2027)
Figure 21. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027)
Figure 23. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027)
Figure 24. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2016-2027)
Figure 25. United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027)
Figure 29. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027)
Figure 30. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2016-2027)
Figure 31. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2016-2027)
Figure 41. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027)
Figure 49. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027)
Figure 50. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2016-2027)
Figure 51. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2016-2027)
Figure 57. Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Roche (Genentech) Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 61. Amgen Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 62. B-MS Revenue Grow

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs